Predictive Biomarkers of Response to Immunotherapy in Metastatic Renal Cell Cancer

INTRODUCTION: In the last decades, the therapeutic decision-making approach to metastatic renal cell cancer (mRCC) has dramatically changed thanks to the introduction in the treatment scenario of, first, anti-angiogenic agents and, afterward, immune-checkpoint inhibitors (ICIs). Immunotherapy is now...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Front Oncol
Prif Awduron: Raimondi, Alessandra, Sepe, Pierangela, Zattarin, Emma, Mennitto, Alessia, Stellato, Marco, Claps, Melanie, Guadalupi, Valentina, Verzoni, Elena, de Braud, Filippo, Procopio, Giuseppe
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2020
Pynciau:
Oncology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7434861/
https://ncbi.nlm.nih.gov/pubmed/32903369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01644
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg